Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Production, purification, crystallization and preliminary X-ray analysis of adeno-associated virus serotype 8Michael Douglas Lane, Hyun Joo Nam, Eric Padron, et al.
Plos One|December 4, 2014
Lenalidomide induces lipid raft assembly to enhance erythropoietin receptor signaling in myelodysplastic syndrome progenitorsKathy L McGraw, Ashley A Basiorka, Joseph O Johnson, et al.
Leukemia Research|January 21, 2014
Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in acute myeloid leukemia from myelodysplastic syndrome after azanucleoside failureMichael V Jaglal, Vu H Duong, Celeste M Bello, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 5, 2017
The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib ApprovalAndrew T Kuykendall, Chetasi Talati, Najla Al Ali, et al.
Blood|November 7, 2024
Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigmAnthony M Hunter, Mrinal M Patnaik, Raphael Itzykson, et al.
Annals of Hematology|November 29, 2023
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbiditiesNathan P Horvat, Enas F Abdallah, Zhuoer Xie, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Second Myeloid Malignancies in a Large Cohort of Patients With Chronic Lymphocytic Leukemia: A Single Institution ExperienceJulio C Chavez, Samir Dalia, Jose Sandoval-Sus, et al.
Annals of Hematology|November 24, 2017
The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromesVu H Duong, Eric Padron, Najla H Al Ali, et al.
Leukemia Research|February 20, 2016
Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemiaYaman Suleiman, Samir Dalia, Jane Jijun Liu, et al.
Annals of Hematology|September 7, 2024
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemiaAkriti G Jain, Virginia O Volpe, Chen Wang, et al.
Pageof 21